MARASCA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.474
AS - Asia 14.894
EU - Europa 12.472
SA - Sud America 1.863
Continente sconosciuto - Info sul continente non disponibili 565
AF - Africa 290
OC - Oceania 53
Totale 61.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.924
GB - Regno Unito 4.409
HK - Hong Kong 3.694
SG - Singapore 3.571
CN - Cina 3.381
IT - Italia 2.340
VN - Vietnam 1.512
BR - Brasile 1.419
SE - Svezia 1.222
DE - Germania 1.029
FI - Finlandia 923
BD - Bangladesh 755
RU - Federazione Russa 571
UA - Ucraina 526
FR - Francia 447
TR - Turchia 433
KR - Corea 308
CA - Canada 298
IN - India 290
ID - Indonesia 222
BG - Bulgaria 212
AR - Argentina 135
NL - Olanda 134
MX - Messico 112
IQ - Iraq 107
JP - Giappone 103
ES - Italia 92
IE - Irlanda 89
EC - Ecuador 76
PL - Polonia 73
ZA - Sudafrica 71
PK - Pakistan 70
CZ - Repubblica Ceca 67
AE - Emirati Arabi Uniti 62
CL - Cile 60
BE - Belgio 56
AT - Austria 52
PH - Filippine 51
AU - Australia 50
VE - Venezuela 49
CO - Colombia 48
MA - Marocco 46
LT - Lituania 41
MY - Malesia 39
KE - Kenya 34
UZ - Uzbekistan 34
SA - Arabia Saudita 33
JM - Giamaica 30
TN - Tunisia 29
DZ - Algeria 26
EG - Egitto 26
PY - Paraguay 26
RO - Romania 26
IR - Iran 24
AZ - Azerbaigian 22
CR - Costa Rica 22
CH - Svizzera 20
JO - Giordania 20
BZ - Belize 19
TW - Taiwan 18
IL - Israele 17
PE - Perù 17
SK - Slovacchia (Repubblica Slovacca) 17
BO - Bolivia 16
NP - Nepal 16
EU - Europa 15
DK - Danimarca 14
ET - Etiopia 14
PT - Portogallo 14
UY - Uruguay 14
RS - Serbia 13
AL - Albania 12
HN - Honduras 11
LB - Libano 11
SI - Slovenia 11
TH - Thailandia 11
DO - Repubblica Dominicana 10
QA - Qatar 10
BY - Bielorussia 9
CY - Cipro 9
GT - Guatemala 9
KZ - Kazakistan 9
SN - Senegal 9
GR - Grecia 8
OM - Oman 8
PS - Palestinian Territory 8
BH - Bahrain 7
LK - Sri Lanka 7
LV - Lettonia 7
PR - Porto Rico 7
SY - Repubblica araba siriana 7
EE - Estonia 6
KG - Kirghizistan 6
KW - Kuwait 6
MD - Moldavia 6
NG - Nigeria 6
NI - Nicaragua 6
PA - Panama 6
TT - Trinidad e Tobago 6
AO - Angola 5
Totale 60.978
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.665
Fairfield 3.249
Ashburn 3.216
Southend 3.187
Santa Clara 2.441
Singapore 2.228
Woodbridge 1.879
Ann Arbor 1.651
Houston 1.496
Chandler 1.448
Seattle 1.262
Wilmington 1.071
Cambridge 1.018
Hefei 984
Jacksonville 976
San Jose 887
Dearborn 839
Nyköping 746
Helsinki 706
London 652
Beijing 594
Los Angeles 562
Ho Chi Minh City 502
Council Bluffs 489
Chicago 473
New York 463
Modena 428
The Dalles 334
Hanoi 318
San Diego 303
Seoul 292
Buffalo 276
Milan 271
Princeton 247
Izmir 228
Sofia 209
Lauterbourg 193
Eugene 189
Munich 185
Salt Lake City 184
Moscow 157
Jakarta 155
Dallas 141
Shanghai 133
São Paulo 122
Fremont 112
Rome 110
Tampa 100
Frankfurt am Main 97
Columbus 96
Bologna 95
Bremen 90
Orem 85
Dublin 83
Phoenix 82
Boardman 80
Elk Grove Village 80
Redwood City 79
Tokyo 78
Toronto 77
Da Nang 70
Des Moines 65
Atlanta 63
Haiphong 63
Montreal 62
Brooklyn 57
Dong Ket 57
Miami 57
Warsaw 53
Brussels 50
Guangzhou 50
Nuremberg 50
Chennai 49
Falls Church 49
Baghdad 45
Lancaster 45
Norwalk 44
Philadelphia 44
Kent 43
Brno 42
Denver 41
Rio de Janeiro 41
Naples 37
Kunming 36
Las Vegas 36
Stockholm 36
Miano 35
San Francisco 35
Turku 33
Mexico City 32
Amsterdam 31
Johannesburg 31
Kilburn 31
Parma 31
Nanjing 30
Reggio Emilia 30
Tashkent 30
Vancouver 30
Boston 29
Dulles 29
Totale 44.115
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 828
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 599
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 585
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 439
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 432
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 423
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 420
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 409
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 407
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 390
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 385
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 373
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 371
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 371
Mucorales-specific T cells in patients with hematologic malignancies 367
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 367
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 361
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 360
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 358
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 356
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 355
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 353
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 350
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 349
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 348
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 345
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 344
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 343
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 342
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 341
The genetics of nodal marginal zone lymphoma 332
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 331
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 328
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage 327
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 327
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 326
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 323
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 322
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia 321
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 320
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 320
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience 318
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 315
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 315
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 314
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 313
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 310
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 310
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 309
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 306
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 305
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 303
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 303
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance 302
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 301
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 300
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 299
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 299
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 297
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 297
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 296
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 295
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 295
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 294
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 292
P53 GENE POINT MUTATIONS IN RELATION TO P53 NUCLEAR-PROTEIN ACCUMULATION IN COLORECTAL CANCERS 290
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 289
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 289
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 288
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival 287
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 286
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 285
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 284
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 284
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 284
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 284
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 284
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 284
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 283
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. 283
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 281
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 280
Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience. 279
Randomized phase 2 study: Elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM 278
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 277
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 277
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia 276
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 276
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 274
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 274
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 274
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 274
Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia 273
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 273
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 270
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 270
Severe anemia in a patient with multiple sclerosis treated with natalizumab 268
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 266
Totale 32.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 243.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 243.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.275 197 548 517 206 99 235 259 192 398 307 698 619
2022/20234.255 503 482 325 374 579 570 81 445 488 51 190 167
2023/20242.972 104 162 172 272 562 270 349 452 54 68 188 319
2024/202510.787 313 123 141 682 1.580 1.278 624 450 2.867 445 985 1.299
2025/202619.305 1.227 1.274 1.683 2.054 2.619 1.259 2.284 924 1.739 1.613 1.624 1.005
2026/2027565 565 0 0 0 0 0 0 0 0 0 0 0
Totale 61.611